id: parenteral_thiamine_administration_to_wks_mortality
name: Parenteral Thiamine Administration → WKS-Related Mortality
from_node:
  node_id: parenteral_thiamine_administration
  node_name: Parenteral Thiamine Administration
to_node:
  node_id: wks_mortality
  node_name: WKS-Related Mortality
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Parenteral thiamine bypasses gastrointestinal absorption issues in alcohol-dependent
  patients'
- 'Step 2: Rapid restoration of thiamine levels prevents progression of acute neurological
  damage'
- 'Step 3: Early intervention reduces risk of fatal complications from Wernicke''s
  encephalopathy'
- 'Step 4: Observational studies show drastically reduced WKS-related mortality with
  parenteral thiamine treatment'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'K. Dingwall et al. 2022. "What is the optimum thiamine dose to
    treat or prevent Wernicke''s encephalopathy or Wernicke–Korsakoff syndrome? Results
    of a randomized controlled trial." *Alcoholism: Clinical and Experimental Research*.
    https://doi.org/10.1111/acer.14843'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.322300'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: healthcare_access
  direction: strengthens
  strength: strong
  description: Access to healthcare facilities that can provide parenteral thiamine
    is critical for mortality reduction
- name: timely_diagnosis
  direction: strengthens
  strength: strong
  description: Early recognition and diagnosis of WE/WKS is essential for effective
    intervention
